These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 27381896)
1. Limited improvement of incorporating primary circulating prostate cells with the CAPRA score to predict biochemical failure-free outcome of radical prostatectomy for prostate cancer. Murray NP; Aedo S; Fuentealba C; Jacob O; Reyes E; Novoa C; Orellana S; Orellana N Urol Oncol; 2016 Oct; 34(10):430.e17-25. PubMed ID: 27381896 [TBL] [Abstract][Full Text] [Related]
2. Prediction model for early biochemical recurrence after radical prostatectomy based on the Cancer of the Prostate Risk Assessment score and the presence of secondary circulating prostate cells. Murray NP; Aedo S; Reyes E; Orellana N; Fuentealba C; Jacob O BJU Int; 2016 Oct; 118(4):556-62. PubMed ID: 26507242 [TBL] [Abstract][Full Text] [Related]
3. Combining the Prostate Cancer Risk Index (PRIX) with the Presence of Secondary Circulating Prostate Cells to Predict the Risk of Biochemical Failure after Radical Prostatectomy for Prostate Cancer. Murray NP; Aedo S; Fuentealba C; Reyes E; Jacob O Asian Pac J Cancer Prev; 2018 Dec; 19(12):3375-3381. PubMed ID: 30583343 [TBL] [Abstract][Full Text] [Related]
4. 10 Year Biochemical Failure Free Survival of Men with CD82 Positive Primary Circulating Prostate Cells Treated by Radical Prostatectomy. Murray NP; Aedo S; Fuentealba C; Reyes E Asian Pac J Cancer Prev; 2018 Jun; 19(6):1577-1583. PubMed ID: 29936782 [TBL] [Abstract][Full Text] [Related]
5. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients. May M; Knoll N; Siegsmund M; Fahlenkamp D; Vogler H; Hoschke B; Gralla O J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the Walz Nomogram and Presence of Secondary Circulating Prostate Cells for Predicting Early Biochemical Failure after Radical Prostatectomy for Prostate Cancer in Chilean Men. Murray NP; Reyes E; Orellana N; Fuentealba C; Jacob O Asian Pac J Cancer Prev; 2015; 16(16):7123-7. PubMed ID: 26514500 [TBL] [Abstract][Full Text] [Related]
7. Elimination of primary circulating prostate cells after radical prostatectomy for prostate cancer decreases the risk of future biochemical failure. Murray NP; Reyes E; Orellana N; Fuentealba C; Dueñas R Arch Esp Urol; 2014 Oct; 67(8):684-91. PubMed ID: 25306986 [TBL] [Abstract][Full Text] [Related]
8. Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort. Cooperberg MR; Davicioni E; Crisan A; Jenkins RB; Ghadessi M; Karnes RJ Eur Urol; 2015 Feb; 67(2):326-33. PubMed ID: 24998118 [TBL] [Abstract][Full Text] [Related]
9. Head to Head Comparison of the Chun Nomogram, Percentage Free PSA and Primary Circulating Prostate Cells to Predict the Presence of Prostate Cancer at Repeat Biopsy. Murray NP; Reyes E; Orellana N; Fuentealba C; Jacob O Asian Pac J Cancer Prev; 2016; 17(6):2941-6. PubMed ID: 27356715 [TBL] [Abstract][Full Text] [Related]
10. [Circulating prostate cells and bone marrow micrometastasis are determinant in risk and time to biochemical progression in localized prostate cancer.]. Murray NP; Aedo S; Fuentealba C; Reyes E; Minzer S; Salazar A Arch Esp Urol; 2019 Jun; 72(5):471-482. PubMed ID: 31223125 [TBL] [Abstract][Full Text] [Related]
11. Outcome of radical prostatectomy in primary circulating prostate cell negative prostate cancer. Murray NP; Aedo S; Reyes E; Fuentealba C; Jacob O Ecancermedicalscience; 2016; 10():671. PubMed ID: 27610197 [TBL] [Abstract][Full Text] [Related]
12. Australian validation of the Cancer of the Prostate Risk Assessment Post-Surgical score to predict biochemical recurrence after radical prostatectomy. Beckmann K; O'Callaghan M; Vincent A; Roder D; Millar J; Evans S; McNeil J; Moretti K ANZ J Surg; 2018 Mar; 88(3):E183-E188. PubMed ID: 28471003 [TBL] [Abstract][Full Text] [Related]
13. [Comparison of two on-line risk calculators versus the detection of circulating prostate cells for the detection of high risk prostate cancer at first biopsy.]. Murray NP; Fuentealba C; Reyes E; Jacob O Arch Esp Urol; 2017 Jun; 70(5):503-512. PubMed ID: 28613202 [TBL] [Abstract][Full Text] [Related]
14. Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy. Punnen S; Freedland SJ; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Carroll PR; Cooperberg MR Eur Urol; 2014 Jun; 65(6):1171-7. PubMed ID: 23587869 [TBL] [Abstract][Full Text] [Related]
15. External validation of the cancer of the prostate risk assessment score to predict biochemical relapse after radical prostatectomy for prostate cancer in Japanese patients. Yoshida T; Nakayama M; Takeda K; Arai Y; Kakimoto K; Nishimura K Urol Int; 2012; 89(1):45-51. PubMed ID: 22441013 [TBL] [Abstract][Full Text] [Related]
16. Does the Presence of Primary Circulating Prostate Cells Imply the Presence of Agressive Prostate Cancer with Early Biochemical Failure: a Comparison with the Walz Nomogram. Murray NP; Reyes E; Orellana N; Fuentealba C; Orellana S; Jacob O Asian Pac J Cancer Prev; 2016; 17(7):3089-93. PubMed ID: 27509934 [TBL] [Abstract][Full Text] [Related]
17. [CAPRA score vs minimal residual disease as predictors of biochemical recurrence after radical prostatectomy.]. Murray NP; Fuentealba C; Reyes E; Salazar A; Guzman E; Orrego S Arch Esp Urol; 2021 Jul; 74(6):554-563. PubMed ID: 34219057 [TBL] [Abstract][Full Text] [Related]
18. External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment score. Zhao KH; Hernandez DJ; Han M; Humphreys EB; Mangold LA; Partin AW Urology; 2008 Aug; 72(2):396-400. PubMed ID: 18372031 [TBL] [Abstract][Full Text] [Related]
19. Identifying the Most Informative Prediction Tool for Cancer-specific Mortality After Radical Prostatectomy: Comparative Analysis of Three Commonly Used Preoperative Prediction Models. Boehm K; Larcher A; Beyer B; Tian Z; Tilki D; Steuber T; Karakiewicz PI; Heinzer H; Graefen M; Budäus L Eur Urol; 2016 Jun; 69(6):1038-43. PubMed ID: 26272236 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of biochemical recurrence-free survival after radical prostatectomy by cancer of the prostate risk assessment post-surgical (CAPRA-S) score. Aktas BK; Ozden C; Bulut S; Tagci S; Erbay G; Gokkaya CS; Baykam MM; Memis A Asian Pac J Cancer Prev; 2015; 16(6):2527-30. PubMed ID: 25824791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]